Cover Image
Market Research Report

Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2019

Published by GlobalData Product code 351424
Published Content info 473 Pages
Delivery time: 1-2 business days
Price
Back to Top
Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2019
Published: December 1, 2019 Content info: 473 Pages
Description

GlobalData's Medical Devices sector report, "Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2019" provides an overview of Immunochemistry Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunochemistry Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Immunochemistry Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Immunochemistry Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Immunochemistry Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME0831EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables 10
  • 1.2 List of Figures 18

2 Introduction 19

  • 2.1 Immunochemistry Analyzers Overview 19

3 Products under Development 20

  • 3.1 Immunochemistry Analyzers - Pipeline Products by Stage of Development 20
  • 3.2 Immunochemistry Analyzers - Pipeline Products by Segment 21
  • 3.3 Immunochemistry Analyzers - Pipeline Products by Territory 22
  • 3.4 Immunochemistry Analyzers - Pipeline Products by Regulatory Path 23
  • 3.5 Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 24
  • 3.6 Immunochemistry Analyzers - Ongoing Clinical Trials 25

4 Immunochemistry Analyzers - Pipeline Products under Development by Companies 26

  • 4.1 Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development 26
  • 4.2 Immunochemistry Analyzers - Pipeline Products by Stage of Development 31

5 Immunochemistry Analyzers Companies and Product Overview 35

6 Immunochemistry Analyzers- Recent Developments 181

  • 6.1 Nov 12, 2019: New breakthrough in Lyme Disease testing reduces time to results from days to minutes 181
  • 6.2 Nov 07, 2019: Trovagene announces third quarter 2019 results and highlights 181
  • 6.3 Nov 06, 2019: Meridian submits Curian analyzer and the Curian HpSA assay to the FDA 184
  • 6.4 Nov 06, 2019: GenMark Diagnostics reports third quarter 2019 results 184
  • 6.5 Nov 06, 2019: Hologic announces financial results for fourth quarter of fiscal 2019 185
  • 6.6 Nov 05, 2019: Thermo Fisher Scientific highlights expanded pharma services capabilities during CPhI 187
  • 6.7 Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance 188
  • 6.8 Oct 31, 2019: BioTek launches a set of quantitative assay apps to simplify detection-based applications 190
  • 6.9 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results 190
  • 6.10 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results. 191
  • 6.11 Oct 31, 2019: SDI Group: Change of name 192
  • 6.12 Oct 30, 2019: First Light Diagnostics joins global initiative to combat antibiotic resistance 192
  • 6.13 Oct 30, 2019: Quidel reports third quarter 2019 financial results 193
  • 6.14 Oct 30, 2019: McKesson reports fiscal 2020 second-quarter results 194
  • 6.15 Oct 30, 2019: Tecan appoints Ralf Griebel a member of the Management Board and Head of Partnering Business 196
  • 6.16 Oct 30, 2019: QIAGEN reports full results for third quarter and first nine months of 2019 196

7 Appendix 468

  • 7.1 Methodology 468
  • 7.2 About GlobalData 471
  • 7.3 Contact Us 471
  • 7.4 Disclaimer 471

List of Tables

  • Table 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development 26
  • Table 2: Immunochemistry Analyzers - Pipeline Products by Segment 27
  • Table 3: Immunochemistry Analyzers - Pipeline Products by Territory 28
  • Table 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path 29
  • Table 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 30
  • Table 6: Immunochemistry Analyzers - Ongoing Clinical Trials 31
  • Table 7: Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development 32
  • Table 8: Immunochemistry Analyzers - Pipeline Products by Stage of Development 37
  • Table 9: Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 10: All-in-One Sensor - Product Status 41
  • Table 11: All-in-One Sensor - Product Description 41
  • Table 12: Acrongenomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 13: BioLED Device - Diabetes Management - Product Status 43
  • Table 14: BioLED Device - Diabetes Management - Product Description 43
  • Table 15: ADOR Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 16: NATlab - Product Status 44
  • Table 17: NATlab - Product Description 44
  • Table 18: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 19: AgPlus Diagnostic System - Product Status 45
  • Table 20: AgPlus Diagnostic System - Product Description 45
  • Table 21: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 22: minDNAnalyzer - Product Status 46
  • Table 23: minDNAnalyzer - Product Description 47
  • Table 24: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 25: TruDx 2000 Platform - Product Status 48
  • Table 26: TruDx 2000 Platform - Product Description 48
  • Table 27: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 28: Clondiag HIV Molecular Device - Product Status 49
  • Table 29: Clondiag HIV Molecular Device - Product Description 49
  • Table 30: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 31: BiliNow - Product Status 50
  • Table 32: BiliNow - Product Description 50
  • Table 33: PKU Now - Product Status 51
  • Table 34: PKU Now - Product Description 51
  • Table 35: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 36: ApoStream System - Product Status 52
  • Table 37: ApoStream System - Product Description 52
  • Table 38: Aptatek BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 39: Point Of Care Diagnostic Device - Phenylketonuria - Product Status 53
  • Table 40: Point Of Care Diagnostic Device - Phenylketonuria - Product Description 53
  • Table 41: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 42: Atolyzer Consumer Device - Product Status 54
  • Table 43: Atolyzer Consumer Device - Product Description 54
  • Table 44: Atolyzer Gene - Product Status 55
  • Table 45: Atolyzer Gene - Product Description 55
  • Table 46: Atolyzer PoC - Product Status 55
  • Table 47: Atolyzer PoC - Product Description 56
  • Table 48: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 49: markB - Product Status 57
  • Table 50: markB - Product Description 57
  • Table 51: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 52: UniCel DxN - Product Status 59
  • Table 53: UniCel DxN - Product Description 59
  • Table 54: Binghampton University Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 55: U-PAC - Product Status 60
  • Table 56: U-PAC - Product Description 60
  • Table 57: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 58: Magnetic Immunoassay Detection System - Product Status 62
  • Table 59: Magnetic Immunoassay Detection System - Product Description 62
  • Table 60: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 61: TR-LFIA Diagnostic Analyzer - Product Status 64
  • Table 62: TR-LFIA Diagnostic Analyzer - Product Description 64
  • Table 63: Biopico Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 64: MONITOR System - Product Status 65

List of Figures

  • Figure 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development 22
  • Figure 2: Immunochemistry Analyzers - Pipeline Products by Segment 23
  • Figure 3: Immunochemistry Analyzers - Pipeline Products by Territory 24
  • Figure 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path 25
  • Figure 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date 26
  • Figure 6: Immunochemistry Analyzers - Ongoing Clinical Trials 27
Back to Top